ALMR
Alamar Biosciences, Inc. · Healthcare · Market cap $1.8B
Insiders sold $47.5M net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Nov 14, 2026
Insider Buying
$8.0M
reported purchases (SEC code P)
Insider Selling
$47.5M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Nov 19, 2026
Qiming Corporate GP VI, Ltd.
Alamar Biosciences, Inc. (ALMR) has 18 SEC Form 4 filings (180 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Nov 19, 2026.
Inside the rolling window, 3 insiders at Alamar Biosciences, Inc. reported 2 open-market purchases totaling $8.0M and 14 open-market sales totaling $47.5M. The most active filer is 10% Owner Qiming Corporate GP VI, Ltd. with 14 filings. Insiders have net sold $47.5M over the trailing 6 months. The most recent open-market filing is a sale of 100,117 shares by 10% Owner Qiming Corporate GP VI, Ltd., dated Nov 11, 2026, worth $2.9M.
- Industry:Biotechnology
- CEO:Yuling Luo
- Employees:222
- HQ:Fremont, CA, US
- IPO:2026-04-17
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Sale | 100,117 | $2.9M | Nov 14 | -13.3% | SEC ↗ | |
| 10% Owner | Sale | 111,313 | $3.3M | Nov 5 | -1.6% | SEC ↗ | |
| 10% Owner | Sale | 143,706 | $4.4M | Nov 3 | — | SEC ↗ | |
| 10% Owner | Sale | 43,930 | $1.3M | Nov 3 | — | SEC ↗ | |
| 10% Owner | Sale | 84,894 | $2.7M | Oct 29 | — | SEC ↗ | |
| 10% Owner | Sale | 100,837 | $3.3M | Oct 29 | — | SEC ↗ | |
| 10% Owner | Sale | 147,934 | $4.5M | Oct 27 | — | SEC ↗ | |
| 10% Owner | Sale | 132,524 | $4.0M | Oct 27 | — | SEC ↗ | |
| 10% Owner | Sale | 208,815 | $6.3M | Oct 23 | — | SEC ↗ | |
| 10% Owner | Sale | 133,811 | $3.9M | Oct 23 | — | SEC ↗ | |
| 10% Owner | Sale | 75,508 | $2.0M | Oct 21 | — | SEC ↗ | |
| 10% Owner | Sale | 142,004 | $4.0M | Oct 21 | — | SEC ↗ | |
Qiming Corporate GP VI, Ltd.First filing | 10% Owner | Sale | 173,537 | $4.8M | Oct 19 | — | SEC ↗ |
Qiming Corporate GP VI, Ltd.First filing | 10% Owner | Sale | 136 | $4K | Oct 19 | — | SEC ↗ |
Naclerio NicholasFirst filing | Insider | Purchase | 235,294 | $4.0M | Apr 20 | — | SEC ↗ |
Illumina Innovation Fund II GP, L.L.C.First filing | 10% Owner | Purchase | 235,294 | $4.0M | Apr 20 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ALMR have?
Alamar Biosciences, Inc. (ALMR) has 18 SEC Form 4 filings (180 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Nov 19, 2026.
When was the most recent SEC Form 4 filing for ALMR?
The most recent Form 4 filing for ALMR on Tracefour is dated Nov 19, 2026.
Who is the most active insider at ALMR?
The most active SEC Form 4 filer at ALMR in the rolling window is 10% Owner Qiming Corporate GP VI, Ltd., with 14 filings.
What is the net insider flow at ALMR over the last 6 months?
Over the trailing 180 days, insiders at ALMR have net sold $47.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ALMR in the current window?
Inside the rolling window, insiders at ALMR bought $8.0M and sold $47.5M based on SEC Form 4 filings.
Can I get alerts for ALMR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Alamar Biosciences, Inc. (ALMR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Alamar Biosciences, Inc. is in the Healthcare sector.